An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01322. Online ahead of print.ABSTRACTResearch has shown that locoregional and/or systemic treatments can reduce the tumor stage, enabling radical surgical resection in patients with initially unresectable hepatocellular carcinoma. This is referred to as conversion therapy. Patients who undergo conversion therapy followed by curative surgery experience a significant survival benefit compared to those who receive chemotherapy alone, those who are successfully downstaged with conversion therapy but not treated with surgery, or those who are treated with upfront surgery. Severa...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Ya-Nan Ma Xuemei Jiang Hui Liu Peipei Song Wei Tang Source Type: research
An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01322. Online ahead of print.ABSTRACTResearch has shown that locoregional and/or systemic treatments can reduce the tumor stage, enabling radical surgical resection in patients with initially unresectable hepatocellular carcinoma. This is referred to as conversion therapy. Patients who undergo conversion therapy followed by curative surgery experience a significant survival benefit compared to those who receive chemotherapy alone, those who are successfully downstaged with conversion therapy but not treated with surgery, or those who are treated with upfront surgery. Severa...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Ya-Nan Ma Xuemei Jiang Hui Liu Peipei Song Wei Tang Source Type: research
An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01322. Online ahead of print.ABSTRACTResearch has shown that locoregional and/or systemic treatments can reduce the tumor stage, enabling radical surgical resection in patients with initially unresectable hepatocellular carcinoma. This is referred to as conversion therapy. Patients who undergo conversion therapy followed by curative surgery experience a significant survival benefit compared to those who receive chemotherapy alone, those who are successfully downstaged with conversion therapy but not treated with surgery, or those who are treated with upfront surgery. Severa...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Ya-Nan Ma Xuemei Jiang Hui Liu Peipei Song Wei Tang Source Type: research
An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01322. Online ahead of print.ABSTRACTResearch has shown that locoregional and/or systemic treatments can reduce the tumor stage, enabling radical surgical resection in patients with initially unresectable hepatocellular carcinoma. This is referred to as conversion therapy. Patients who undergo conversion therapy followed by curative surgery experience a significant survival benefit compared to those who receive chemotherapy alone, those who are successfully downstaged with conversion therapy but not treated with surgery, or those who are treated with upfront surgery. Severa...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Ya-Nan Ma Xuemei Jiang Hui Liu Peipei Song Wei Tang Source Type: research
An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01322. Online ahead of print.ABSTRACTResearch has shown that locoregional and/or systemic treatments can reduce the tumor stage, enabling radical surgical resection in patients with initially unresectable hepatocellular carcinoma. This is referred to as conversion therapy. Patients who undergo conversion therapy followed by curative surgery experience a significant survival benefit compared to those who receive chemotherapy alone, those who are successfully downstaged with conversion therapy but not treated with surgery, or those who are treated with upfront surgery. Severa...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Ya-Nan Ma Xuemei Jiang Hui Liu Peipei Song Wei Tang Source Type: research
An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01322. Online ahead of print.ABSTRACTResearch has shown that locoregional and/or systemic treatments can reduce the tumor stage, enabling radical surgical resection in patients with initially unresectable hepatocellular carcinoma. This is referred to as conversion therapy. Patients who undergo conversion therapy followed by curative surgery experience a significant survival benefit compared to those who receive chemotherapy alone, those who are successfully downstaged with conversion therapy but not treated with surgery, or those who are treated with upfront surgery. Severa...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Ya-Nan Ma Xuemei Jiang Hui Liu Peipei Song Wei Tang Source Type: research
An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01322. Online ahead of print.ABSTRACTResearch has shown that locoregional and/or systemic treatments can reduce the tumor stage, enabling radical surgical resection in patients with initially unresectable hepatocellular carcinoma. This is referred to as conversion therapy. Patients who undergo conversion therapy followed by curative surgery experience a significant survival benefit compared to those who receive chemotherapy alone, those who are successfully downstaged with conversion therapy but not treated with surgery, or those who are treated with upfront surgery. Severa...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Ya-Nan Ma Xuemei Jiang Hui Liu Peipei Song Wei Tang Source Type: research
An update on diagnosis and treatment of hepatoblastoma
Biosci Trends. 2023 Dec 23. doi: 10.5582/bst.2023.01311. Online ahead of print.ABSTRACTHepatoblastoma (HB) remains the most common paediatric liver tumour and survival in children with hepatoblastoma has improved considerably since the advent of sequential surgical regimens of chemotherapy based on platinum-based chemotherapeutic agents in the 1980s. With the advent of modern diagnostic imaging and pathology techniques, new preoperative chemotherapy regimens and the maturation of surgical techniques, new diagnostic and treatment options for patients with hepatoblastoma have emerged and international collaborations are inve...
Source: BioScience Trends - December 24, 2023 Category: Biomedical Science Authors: Yinbiao Cao Shurui Wu Haowen Tang Source Type: research
